Literature DB >> 25846528

Systolic and mean pulmonary artery pressures: are they interchangeable in patients with pulmonary hypertension?

Denis Chemla1, Marc Humbert2, Olivier Sitbon2, David Montani2, Philippe Hervé2.   

Abstract

Pulmonary hypertension (PH) is a common complication of numerous diseases, including left-sided heart diseases and chronic lung diseases and/or hypoxia, where PH is associated with exercise limitation and a worse prognosis. Other forms of PH include pulmonary arterial hypertension (PAH), chronic thromboembolic PH (CTEPH), and PH with unclear multifactorial mechanisms. Over the past decade, it has been documented that systolic pulmonary artery pressure (sPAP) may help estimate mean pulmonary artery pressure (mPAP) in adults with high accuracy and reasonably good precision (mPAP = 0.61 sPAP + 2 mm Hg). This strong linear relationship between sPAP and mPAP was unexpected from a classic physiologic point of view. Consistent results have been obtained from independent teams using either high-fidelity micromanometer-tipped PA catheters or fluid-filled catheters. Overall, the strong link between sPAP and mPAP has been documented over a wide range of PAPs, heart rate, cardiac output, wedge pressure, and causes of PH, during changes in posture and activity, and irrespective of patient's sex, age, and BMI. A review of available invasive data confirms that patients with CTEPH and idiopathic PAH matched for their mPAP exhibit essentially similar sPAP. Pressure redundancy may be explained by the dependence of PA compliance upon mPAP. The 25 mm Hg threshold used to define PH accurately corresponds to an sPAP of 38 mm Hg. Although the limits of the echocardiographic estimation of sPAP are widely documented, results from invasive studies may furnish an evidence-based sPAP-derived mPAP value, potentially useful in the multiparameter echocardiographic approach currently used to diagnose and follow patients with PH.

Entities:  

Mesh:

Year:  2015        PMID: 25846528     DOI: 10.1378/chest.14-1755

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  16 in total

1.  Elevated Pulmonary Artery Systolic Pressure is Associated with Poor Survival of Patients with Non-Small Cell Lung Cancer.

Authors:  Xue Yang; Lina Wang; Lianjun Lin; Xinmin Liu
Journal:  Cancer Manag Res       Date:  2020-07-27       Impact factor: 3.989

2.  Pulmonary hypertension and post-operative outcome in renal transplant: A retrospective analysis of 170 patients.

Authors:  Vipin Kumar Goyal; Sohan Lal Solanki; Birbal Baj
Journal:  Indian J Anaesth       Date:  2018-02

3.  A critical appraisal of transpulmonary and diastolic pressure gradients.

Authors:  M Louis Handoko; Frances S De Man; Frank P T Oosterveer; Harm-Jan Bogaard; Anton Vonk-Noordegraaf; Nico Westerhof
Journal:  Physiol Rep       Date:  2016-09

4.  Impact of type and size of annuloplasty prosthesis on hemodynamic status after mitral valve repair for degenerative disease.

Authors:  Arudo Hiraoka; Akihiro Hayashida; Misako Toki; Genta Chikazawa; Hidenori Yoshitaka; Kiyoshi Yoshida; Taichi Sakaguchi
Journal:  Int J Cardiol Heart Vasc       Date:  2020-04-24

5.  Congenital Heart Defect and Pulmonary Hypertension in Children With Down Syndrome: Clinical Profile Over Two Decades.

Authors:  Abdullah N Alhuzaimi; Najoud M Alotaibi; Ghadah I Alsuhaibani; Reem K Alanazi; Mohamad-Hani Temsah
Journal:  Cureus       Date:  2021-02-07

6.  The effects of ductal size on the severity of pulmonary hypertension in children with patent ductus arteriosus (PDA): a multi-center study.

Authors:  Josephat M Chinawa; Bartholomew F Chukwu; Awoere T Chinawa; Chika O Duru
Journal:  BMC Pulm Med       Date:  2021-03-05       Impact factor: 3.317

7.  Prognostication of Poor Survival After Cardiac Resynchronization Therapy.

Authors:  Paulius Bašinskas; Neris Stoškutė; Austėja Gerulytė; Agnė Abramavičiūtė; Aras Puodžiukynas; Tomas Kazakevičius
Journal:  Medicina (Kaunas)       Date:  2020-01-04       Impact factor: 2.430

8.  Natriuretic peptide receptor C contributes to disproportionate right ventricular hypertrophy in a rodent model of obesity-induced heart failure with preserved ejection fraction with pulmonary hypertension.

Authors:  Vineet Agrawal; Niki Fortune; Sheeline Yu; Julio Fuentes; Fubiao Shi; David Nichols; Linda Gleaves; Emily Poovey; Thomas J Wang; Evan L Brittain; Sheila Collins; James D West; Anna R Hemnes
Journal:  Pulm Circ       Date:  2019-12-18       Impact factor: 3.017

9.  Cardiovascular magnetic resonance 4D flow analysis has a higher diagnostic yield than Doppler echocardiography for detecting increased pulmonary artery pressure.

Authors:  Joao G Ramos; Alexander Fyrdahl; Björn Wieslander; Gert Reiter; Ursula Reiter; Ning Jin; Eva Maret; Maria Eriksson; Kenneth Caidahl; Peder Sörensson; Andreas Sigfridsson; Martin Ugander
Journal:  BMC Med Imaging       Date:  2020-03-06       Impact factor: 1.930

10.  IPF patients are limited by mechanical and not pulmonary-vascular factors - results of a derivation-validation cohort study.

Authors:  Benjamin D Fox; Yael Shostak; Barak Pertzov; Baruch Vainshelboim; Shimon Itzhakian; Irit Terner; Mordechai R Kramer
Journal:  BMC Pulm Med       Date:  2019-12-11       Impact factor: 3.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.